Literature DB >> 8176557

Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome.

A S Mistchenko1, R A Diez, A L Mariani, J Robaldo, A F Maffey, G Bayley-Bustamante, S Grinstein.   

Abstract

To explore the pathogenic mechanisms involved in adenovirus infection, we evaluated total levels of immunoglobulins, antiadenovirus antibodies, adenovirus-specific circulating immune complexes, and cytokines in serum samples obtained from 38 hospitalized children with adenovirus infection. According to their clinical findings and outcome, the infections were classified as follows: (1) moderate (group I, n = 10), (2) severe (group II, n = 12), and (3) fatal (group III, n = 16). About 60% of the children had elevated IgM levels. IgG-containing adenovirus-specific circulating immune complexes were initially detected in 7 of 16 group III patients, 4 of whom had low serum levels of the third component of complement. A decrease in initial antiadenovirus IgG antibodies was observed in 3 of 10 patients in group III. Serum interleukin-6 was not detected in group I (none of 10), but was present in group II (7 of 12, p = 0.016) and group III (13 of 16, p < 0.001). Interleukin-8 was detected in all groups; values in fatal cases were significantly higher than in surviving children. Tumor necrosis factor alpha was not observed in group I (none of 10) and was uncommon in group II (2 of 12) but was frequently detected in group III (9 of 15, p = 0.01). Interleukin-1 and interleukin-4 were rarely detected in serum samples. Increased concentrations of interleukin-6, interleukin-8, and tumor necrosis factor alpha were associated with hypoperfusion, febrile peaks, tonic-clonic seizures, and septic shock. In 5 of 10 patients in groups II and III, autoantibodies specific for smooth muscle were found. Our findings indicate that high serum values for interleukin-6, interleukin-8, and tumor necrosis factor alpha are associated with severity of adenovirus infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176557     DOI: 10.1016/s0022-3476(05)81360-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  27 in total

Review 1.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

Review 2.  Adenovirus sensing by the immune system.

Authors:  Svetlana Atasheva; Dmitry M Shayakhmetov
Journal:  Curr Opin Virol       Date:  2016-09-14       Impact factor: 7.090

3.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

Review 4.  Adenovirus-triggered innate signalling pathways.

Authors:  G Fejer; M Freudenberg; U F Greber; I Gyory
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

5.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

Review 6.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis.

Authors:  A J Colom; A M Teper; W M Vollmer; G B Diette
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

8.  Association between cytokine gene polymorphisms and risk for upper respiratory tract infection and acute otitis media.

Authors:  Krystal Revai; Janak A Patel; James J Grady; Sangeeta Nair; Reuben Matalon; Tasnee Chonmaitree
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

9.  Viral upper respiratory tract infection and otitis media complication in young children.

Authors:  Tasnee Chonmaitree; Krystal Revai; James J Grady; Audra Clos; Janak A Patel; Sangeeta Nair; Jiang Fan; Kelly J Henrickson
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

10.  Inhibition of intrahepatic gamma interferon production by hepatitis C virus nonstructural protein 5A in transgenic mice.

Authors:  Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.